Skip to main content
logo
Entrada Therapeutics, Inc. (TRDA)
NASDAQ: TRDA · Real-Time Price · USD
7.57
+0.44 (6.17%)
Sep 8, 2026, 1:00 PM EDT - Market open

Entrada Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Quarter
CurrentQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Sep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Market Capitalization
273265454369206237322612562500458503525503480424493377293534-
Market Cap Growth (YoY)
44.31%11.94%41.07%-39.78%-63.33%-52.66%-29.70%21.70%7.07%-0.43%-4.47%18.72%6.50%33.23%63.44%-20.71%-----
Enterprise Value
986021094-93-89-392241572391742192211073172362791452610-
Last Close Price
7.137.3612.6210.285.806.729.0417.2915.9814.2514.1715.0915.8015.1414.5013.5215.7612.189.3917.12-

Price Ratios

Fiscal Quarter
CurrentQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Sep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
PE Ratio
------13.009.3310.234.7919.51----------
PS Ratio
54.8656.6079.1814.503.352.981.872.902.612.092.813.906.0311.5718.99------
PB Ratio
1.101.141.681.200.610.620.771.431.331.161.702.082.132.432.091.992.111.471.061.79-
P/TBV Ratio
1.101.141.681.200.610.620.771.431.331.161.702.082.132.432.091.992.111.471.061.79-
P/FCF Ratio
-----------3.754.724.623.79------
P/OCF Ratio
-----------3.604.514.433.67------

EV Ratios

Fiscal Quarter
CurrentQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Sep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
EV/Sales Ratio
17.6312.8336.523.71---1.060.731.001.071.692.542.4712.54------
EV/EBITDA Ratio
-------4.412.562.476.47----------
EV/EBIT Ratio
-------4.772.722.567.35----------
EV/FCF Ratio
-----------1.631.990.992.50------

Financial Efficiency

Fiscal Quarter
CurrentQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Sep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Debt / Equity Ratio
0.210.210.180.170.150.140.140.140.140.150.250.280.280.350.070.120.120.120.12--
Debt / EBITDA Ratio
------2.720.920.810.581.584.68---------
Debt / FCF Ratio
-----------0.510.620.670.13------
Net Debt / Equity Ratio
-0.75-0.75-0.76-0.80-0.80-0.79-0.78-0.84-0.92-0.94-0.97-1.17-1.15-1.47-1.72-0.77-0.80-0.84-0.84-0.97-0.98
Net Debt / EBITDA Ratio
1.021.021.191.612.343.24-41.24-7.10-6.33-4.18-9.68883.929.174.265.021.712.122.783.655.823.02
Net Debt / FCF Ratio
1.301.301.561.892.112.375.618.0722.2221.912.78-2.11-2.56-2.79-3.121.682.072.783.425.252.93
Asset Turnover
0.010.010.010.060.130.150.350.420.410.450.330.360.230.110.06------
Quick Ratio
10.5210.5213.4012.2013.7418.0521.0010.786.425.582.332.262.173.032.888.6210.0013.5117.1143.3217.07
Current Ratio
10.8910.8913.9012.5314.0818.6421.8811.156.595.712.382.332.323.102.949.5510.8914.0517.6844.4617.26
Return on Equity (ROE)
-54.10%-54.10%-48.28%-39.13%-27.11%-18.13%7.22%19.56%16.43%32.80%9.41%-2.94%-9.07%-35.58%-31.41%-37.01%-49.39%-39.40%-40.59%-30.19%-
Return on Assets (ROA)
-29.20%-29.20%-26.84%-21.58%-15.71%-11.66%0.52%5.90%6.95%10.86%3.01%-0.55%-5.54%-11.65%-12.76%-21.79%-27.69%-22.35%--18.29%-
Return on Invested Capital (ROIC)
-280.08%-280.08%-277.73%-244.42%-165.93%-111.83%5.15%90.72%140.75%535.83%------203.92%-206.48%-180.50%-244.85%-985.11%-1942.64%
Return on Capital Employed (ROCE)
-62.90%-62.90%-55.80%-44.20%-31.30%-22.40%0.90%9.70%11.90%18.80%7.00%-1.00%-10.50%-20.00%-24.70%-42.30%-35.60%-28.30%-21.50%-17.10%-33.00%

Yields

Fiscal Quarter
CurrentQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Sep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Earnings Yield
-64.48%-62.51%-36.56%-38.99%-50.17%-30.96%7.69%10.72%9.77%20.87%5.13%-1.33%-4.15%-16.39%-16.60%-22.33%-17.94%-20.61%-21.96%-9.57%-
FCF Yield
-52.26%-50.66%-28.98%-35.14%-62.94%-53.42%-18.01%-7.30%-3.11%-3.70%-20.50%26.68%21.17%21.65%26.41%-22.82%-18.36%-20.44%-23.10%-10.38%-
Buyback Yield / Dilution
-1.93%-1.93%-2.44%-6.07%-15.95%-19.72%-20.56%-18.01%-9.14%-6.84%-6.59%-5.62%-13.36%-50.79%-129.38%-399.27%-2090.29%-1632.69%-1089.36%-467.09%-40.47%
SEC Filings: 10-K · 10-Q